MX2014014350A - Nueva forma de dosificacion y formulacion de abediterol. - Google Patents
Nueva forma de dosificacion y formulacion de abediterol.Info
- Publication number
- MX2014014350A MX2014014350A MX2014014350A MX2014014350A MX2014014350A MX 2014014350 A MX2014014350 A MX 2014014350A MX 2014014350 A MX2014014350 A MX 2014014350A MX 2014014350 A MX2014014350 A MX 2014014350A MX 2014014350 A MX2014014350 A MX 2014014350A
- Authority
- MX
- Mexico
- Prior art keywords
- abediterol
- formulation
- dosage form
- inhalation
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona, una composición farmacéutica en forma de polvo seco para inhalación que comprende abediterol o una sal farmacéuticamente aceptable del mismo en mezcla con un excipiente inerte farmacéuticamente aceptable, que proporciona al ser inhalada una dosis equivalente a una dosis nominal medida de aproximadamente 1,25 o aproximadamente 2,5 de base libre abediterol administrada con el inhalador Genuair(r). La presente invención también proporciona dicha composición farmacéutica para uso en el tratamiento de una enfermedad respiratoria tal como asma y enfermedad pulmonar obstructiva crónica EPOC.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382221.5A EP2668941A1 (en) | 2012-05-31 | 2012-05-31 | Novel dosage form and formulation of abediterol |
US201261660003P | 2012-06-15 | 2012-06-15 | |
PCT/EP2013/061181 WO2013178742A1 (en) | 2012-05-31 | 2013-05-30 | Novel dosage form and formulation of abediterol |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014014350A true MX2014014350A (es) | 2015-03-03 |
Family
ID=46317311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014014350A MX2014014350A (es) | 2012-05-31 | 2013-05-30 | Nueva forma de dosificacion y formulacion de abediterol. |
Country Status (29)
Country | Link |
---|---|
US (2) | US20150140099A1 (es) |
EP (2) | EP2668941A1 (es) |
JP (1) | JP6272836B2 (es) |
KR (2) | KR20150018526A (es) |
CN (1) | CN104394852A (es) |
AR (1) | AR091233A1 (es) |
AU (1) | AU2013269565B2 (es) |
BR (1) | BR112014029735A2 (es) |
CA (1) | CA2871358C (es) |
CL (1) | CL2014003286A1 (es) |
CO (1) | CO7141434A2 (es) |
CR (1) | CR20140540A (es) |
DO (1) | DOP2014000271A (es) |
EA (1) | EA201401354A1 (es) |
EC (1) | ECSP14028814A (es) |
HK (1) | HK1203149A1 (es) |
IL (1) | IL235831B (es) |
IN (1) | IN2014DN08672A (es) |
MX (1) | MX2014014350A (es) |
MY (1) | MY184654A (es) |
NI (1) | NI201400139A (es) |
NZ (1) | NZ701261A (es) |
PE (1) | PE20150171A1 (es) |
PH (1) | PH12014502662A1 (es) |
SG (3) | SG10201609119VA (es) |
TW (1) | TWI610690B (es) |
UY (1) | UY34838A (es) |
WO (1) | WO2013178742A1 (es) |
ZA (1) | ZA201407405B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
US20150224197A1 (en) * | 2012-07-05 | 2015-08-13 | Arven Ilac Sanayi Ve Ticaret A.S. | Inhalation compositions |
WO2015193631A1 (en) * | 2014-06-18 | 2015-12-23 | Cipla Limited | Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent |
WO2019142214A1 (en) * | 2018-01-19 | 2019-07-25 | Cipla Limited | Pharmaceutical composition comprising tiotropium for inhalation |
WO2019226697A1 (en) | 2018-05-22 | 2019-11-28 | C.R. Bard, Inc. | Catheterization system and methods for use thereof |
JP7314252B2 (ja) | 2018-08-10 | 2023-07-25 | シー・アール・バード・インコーポレーテッド | 自動尿量測定システム |
US11931151B2 (en) | 2020-12-22 | 2024-03-19 | C. R. Bard, Inc. | Automated urinary output measuring system |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT7920688V0 (it) | 1979-02-05 | 1979-02-05 | Chiesi Paolo Parma | Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore. |
CY1492A (en) | 1981-07-08 | 1990-02-16 | Draco Ab | Powder inhalator |
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FI69963C (fi) | 1984-10-04 | 1986-09-12 | Orion Yhtymae Oy | Doseringsanordning |
DE3927170A1 (de) | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
IT1237118B (it) | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
DE4027391A1 (de) | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgeraet |
WO1992004928A2 (en) | 1990-09-26 | 1992-04-02 | Pharbita B.V. | Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber |
GB9026025D0 (en) | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
DE4239402A1 (de) | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
HU215510B (hu) | 1992-12-18 | 1999-01-28 | Schering Corp. | Inhalátor por alakú gyógyszerekhez |
PT837710E (pt) | 1995-06-21 | 2002-05-31 | Sofotec Gmbh & Co Kg | Cartucho de po farmaceutico com dispositivo de doseamento integrado e inalador para medicamentos em po |
DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
ITMI20010357U1 (it) | 2001-06-28 | 2002-12-30 | Plastiape Spa | Dispositivo inalatore |
ES2195785B1 (es) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2211344B1 (es) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
CA2540005A1 (en) * | 2003-09-26 | 2005-04-07 | Schering Corporation | Pulmonary disease treatment |
ES2232306B1 (es) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
GB0410712D0 (en) | 2004-05-13 | 2004-06-16 | Novartis Ag | Organic compounds |
ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2251867B1 (es) | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
DE602005023690D1 (de) | 2004-07-16 | 2010-11-04 | Almirall Sa | Inhalator für die Abgabe von pharmzeutischen Pulver, und ein Pulverkassette zur Verwendung mit diesem Inhalator |
ES2265276B1 (es) | 2005-05-20 | 2008-02-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
ES2306595B1 (es) * | 2007-02-09 | 2009-09-11 | Laboratorios Almirall S.A. | Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2. |
EP2100598A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
UY32297A (es) | 2008-12-22 | 2010-05-31 | Almirall Sa | Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico |
EP2221055A1 (en) * | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function |
EP2221297A1 (en) * | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases |
-
2012
- 2012-05-31 EP EP12382221.5A patent/EP2668941A1/en not_active Withdrawn
-
2013
- 2013-05-30 AU AU2013269565A patent/AU2013269565B2/en not_active Ceased
- 2013-05-30 CA CA2871358A patent/CA2871358C/en active Active
- 2013-05-30 SG SG10201609119VA patent/SG10201609119VA/en unknown
- 2013-05-30 SG SG10201913424SA patent/SG10201913424SA/en unknown
- 2013-05-30 MY MYPI2014703543A patent/MY184654A/en unknown
- 2013-05-30 JP JP2015514503A patent/JP6272836B2/ja not_active Expired - Fee Related
- 2013-05-30 CN CN201380028903.4A patent/CN104394852A/zh active Pending
- 2013-05-30 WO PCT/EP2013/061181 patent/WO2013178742A1/en active Application Filing
- 2013-05-30 EP EP13728344.6A patent/EP2854771A1/en not_active Withdrawn
- 2013-05-30 PE PE2014002064A patent/PE20150171A1/es not_active Application Discontinuation
- 2013-05-30 IN IN8672DEN2014 patent/IN2014DN08672A/en unknown
- 2013-05-30 EA EA201401354A patent/EA201401354A1/ru unknown
- 2013-05-30 TW TW102119230A patent/TWI610690B/zh not_active IP Right Cessation
- 2013-05-30 NZ NZ701261A patent/NZ701261A/en not_active IP Right Cessation
- 2013-05-30 MX MX2014014350A patent/MX2014014350A/es unknown
- 2013-05-30 US US14/404,199 patent/US20150140099A1/en not_active Abandoned
- 2013-05-30 BR BR112014029735A patent/BR112014029735A2/pt not_active Application Discontinuation
- 2013-05-30 KR KR1020147033563A patent/KR20150018526A/ko active Application Filing
- 2013-05-30 SG SG11201407110QA patent/SG11201407110QA/en unknown
- 2013-05-30 KR KR1020187026487A patent/KR20180104197A/ko not_active Application Discontinuation
- 2013-05-31 UY UY0001034838A patent/UY34838A/es not_active Application Discontinuation
- 2013-05-31 AR ARP130101927 patent/AR091233A1/es unknown
-
2014
- 2014-10-13 ZA ZA2014/07405A patent/ZA201407405B/en unknown
- 2014-11-20 IL IL235831A patent/IL235831B/en active IP Right Grant
- 2014-11-25 NI NI201400139A patent/NI201400139A/es unknown
- 2014-11-26 CR CR20140540A patent/CR20140540A/es unknown
- 2014-11-26 DO DO2014000271A patent/DOP2014000271A/es unknown
- 2014-11-26 EC ECIEPI201428814A patent/ECSP14028814A/es unknown
- 2014-11-27 CO CO14260864A patent/CO7141434A2/es unknown
- 2014-11-28 PH PH12014502662A patent/PH12014502662A1/en unknown
- 2014-11-28 CL CL2014003286A patent/CL2014003286A1/es unknown
-
2015
- 2015-04-16 HK HK15103713.3A patent/HK1203149A1/xx unknown
-
2016
- 2016-06-30 US US15/198,289 patent/US20160303108A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA101653C2 (uk) | Композиція для інгаляції, що містить аклідиній для лікування астми та хронічного обструктивного захворювання легень | |
PH12014502662A1 (en) | Novel dosage form and formulation of abediterol | |
UA101652C2 (uk) | Композиція для інгаляції, що містить аклідиній для лікування астми та хронічного обструктивного захворювання легень | |
MY179703A (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
WO2013021199A3 (en) | Eutectic mixture for pulmonary administration | |
AR067639A1 (es) | Medicamentos pulverulentos que contienen tiotropio y salmetrol, asi como lactosa como excipiente | |
WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
EA201590030A1 (ru) | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент | |
MD20140131A2 (ro) | Doză şi formă preparativă nouă pentru inhalare care cuprinde aclidiniu | |
MX2015015132A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
EA201590019A1 (ru) | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы | |
MX2015015150A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
UA115989C2 (uk) | Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії | |
JO3024B1 (ar) | صيغ أيروسول صيدلانية من الفرموتيرول وبكلوميتازون داي بروبيونات | |
MY187442A (en) | A pharmaceutical composition containing budesonide and formoterol | |
MY191295A (en) | Pharmaceutical composition containing budesonide and formoterol | |
TN2013000015A1 (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
TH1401007107A (th) | รูปฟอร์มขนาดใช้ยา และ สูตรผสมใหม่ของเอบีไดเทอรอล | |
GR1008468B (el) | Μιγμα σισπλατινης σε μορφη λεπτοκοκκης εισπνεομενης ξηρας σκονης | |
BR112014028864A2 (pt) | dosagem e formulação |